The critical limb ischemia market is growing as diabetes, cardiovascular disease, peripheral artery disease, and aging populations increase the need for advanced vascular diagnostics and treatment. The market was valued at USD 3.63 billion in 2024 and is projected to reach USD 5.5 billion by 2032, at a CAGR of 5.33%.wiseguyreports Critical limb ischemia is a severe form of peripheral arterial...

The gastrointestinal stent market is growing as healthcare providers increasingly use minimally invasive technologies to manage obstructions in the digestive tract. The market was valued at USD 1.96 billion in 2024 and is projected to reach USD 3.0 billion by 2032, expanding at a CAGR of 5.48%.wiseguyreports Gastrointestinal stents are medical devices used to help maintain or restore passage...

The newborn screening for spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) market is growing as healthcare systems prioritize early detection of rare but serious genetic disorders. The market was valued at USD 2.09 billion in 2024 and is projected to reach USD 3.2 billion by 2032, growing at a CAGR of 5.48%.wiseguyreports SMA affects motor neurons and can lead to...